.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Dow
UBS
Boehringer Ingelheim
Citi
Novartis
Argus Health
Cerilliant
Fish and Richardson
Deloitte

Generated: June 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006071

« Back to Dashboard
NDA 006071 describes BEROCCA PN, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the BEROCCA PN profile page.

The generic ingredient in BEROCCA PN is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin e profile page.

Summary for NDA: 006071

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A PALMITATE','VITAMIN E') AND hsdb_dru' at line 1
Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1